Generic Viagra launches
June 27, 2013
Mylan has launched generic
versions of Viagra in 11 countries in
Europe in 3 strengths: 25mg, 50mg,
and 100mg.
Mylan has received marketing
authorisation from each country’s
respective health authority to begin
selling its product immediately.
Sildenafil Citrate is the generic
version of Pfizer’s Viagra, and is
indicated for the treatment of
erectile dysfunction.
Viagra had total sales of €241.1
million (A$335 million) in France,
the United Kingdom, Ireland,
Italy, Belgium, Slovakia, Germany,
Denmark, Czech Republic, Spain
and the Netherlands for the twelve
months ending March 31, 2013,
according to IMS Health.
Pfizer’s patent on Viagra is due to
expire in 2019 in the USA and 2014
in Australia.
Other erectile dysfunction
products available in Australia,
Cialis and Levitra, are still in patent.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jun 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jun 13